Treatment for breast cancers are guided by the identification of hormone receptors, Estrogen receptor (ER), Progesterone receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2) (2, 3). This evidence concerns the gene ERBB2 and breast carcinoma.